These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 23685547

  • 1. Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat.
    Hanson GR, Hoonakker AJ, Robson CM, McFadden LM, Frankel PS, Alburges ME.
    J Pharmacol Exp Ther; 2013 Aug; 346(2):173-81. PubMed ID: 23685547
    [Abstract] [Full Text] [Related]

  • 2. Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia.
    Frankel PS, Hoonakker AJ, Alburges ME, McDougall JW, McFadden LM, Fleckenstein AE, Hanson GR.
    J Pharmacol Exp Ther; 2011 Mar; 336(3):809-15. PubMed ID: 21131268
    [Abstract] [Full Text] [Related]

  • 3. Response of limbic neurotensin systems to methamphetamine self-administration.
    Hanson GR, Hoonakker AJ, Alburges ME, McFadden LM, Robson CM, Frankel PS.
    Neuroscience; 2012 Feb 17; 203():99-107. PubMed ID: 22245499
    [Abstract] [Full Text] [Related]

  • 4. Differential response of neurotensin to methamphetamine self-administration.
    Frankel PS, Hoonakker AJ, Hanson GR.
    Ann N Y Acad Sci; 2008 Oct 17; 1139():112-7. PubMed ID: 18991855
    [Abstract] [Full Text] [Related]

  • 5. Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.
    Alburges ME, Hoonakker AJ, Cordova NM, Robson CM, McFadden LM, Martin AL, Hanson GR.
    Psychopharmacology (Berl); 2014 Aug 17; 231(15):2933-40. PubMed ID: 24522333
    [Abstract] [Full Text] [Related]

  • 6. Mephedrone alters basal ganglia and limbic neurotensin systems.
    German CL, Hoonakker AH, Fleckenstein AE, Hanson GR.
    J Neurochem; 2014 Aug 17; 130(3):402-7. PubMed ID: 24678634
    [Abstract] [Full Text] [Related]

  • 7. Effect of low doses of methamphetamine on rat limbic-related neurotensin systems.
    Alburges ME, Hoonakker AJ, Cordova NM, Robson CM, McFadden LM, Martin AL, Hanson GR.
    Synapse; 2015 Aug 17; 69(8):396-404. PubMed ID: 25963809
    [Abstract] [Full Text] [Related]

  • 8. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
    McCormick SE, Stoessl AJ.
    Neuroscience; 2003 Aug 17; 119(2):547-55. PubMed ID: 12770567
    [Abstract] [Full Text] [Related]

  • 9. Antagonism of Neurotensin Receptors in the Ventral Tegmental Area Decreases Methamphetamine Self-Administration and Methamphetamine Seeking in Mice.
    Dominguez-Lopez S, Piccart E, Lynch WB, Wollet MB, Sharpe AL, Beckstead MJ.
    Int J Neuropsychopharmacol; 2018 Apr 01; 21(4):361-370. PubMed ID: 29272412
    [Abstract] [Full Text] [Related]

  • 10. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat.
    Boules M, Iversen I, Oliveros A, Shaw A, Williams K, Robinson J, Fredrickson P, Richelson E.
    Brain Res; 2007 Jan 05; 1127(1):90-8. PubMed ID: 17113052
    [Abstract] [Full Text] [Related]

  • 11. Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation.
    Sharpe AL, Varela E, Beckstead MJ.
    PLoS One; 2017 Jan 05; 12(7):e0180710. PubMed ID: 28686721
    [Abstract] [Full Text] [Related]

  • 12. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
    Chapman DE, Hanson GR, Kesner RP, Keefe KA.
    J Pharmacol Exp Ther; 2001 Feb 05; 296(2):520-7. PubMed ID: 11160639
    [Abstract] [Full Text] [Related]

  • 13. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.
    Alburges ME, Hoonakker AJ, Horner KA, Fleckenstein AE, Hanson GR.
    J Neurochem; 2011 May 05; 117(3):470-8. PubMed ID: 21323925
    [Abstract] [Full Text] [Related]

  • 14. Intra-accumbens shell injections of SR48692 enhanced cocaine self-administration intake in rats exposed to an environmentally-elicited reinstatement paradigm.
    Ramos-Ortolaza DL, Negrón A, Cruz D, Falcón E, Iturbe MC, Cajigas MH, Maldonado-Vlaar CS.
    Brain Res; 2009 Jul 14; 1280():124-36. PubMed ID: 19442653
    [Abstract] [Full Text] [Related]

  • 15. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist.
    Díaz-Cabiale Z, Fuxe K, Narváez JA, Finetti S, Antonelli T, Tanganelli S, Ferraro L.
    Neuroreport; 2002 May 07; 13(6):763-6. PubMed ID: 11997683
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological activation of the neurotensin receptor 1 abrogates the methamphetamine-induced striatal apoptosis in the mouse brain.
    Liu Q, Hazan A, Grinman E, Angulo JA.
    Brain Res; 2017 Mar 15; 1659():148-155. PubMed ID: 28130052
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1994 Jul 15; 270(1):192-7. PubMed ID: 7913495
    [Abstract] [Full Text] [Related]

  • 18. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
    Petkova-Kirova P, Rakovska A, Zaekova G, Ballini C, Corte LD, Radomirov R, Vágvölgyi A.
    Neurochem Int; 2008 Dec 15; 53(6-8):355-61. PubMed ID: 18835308
    [Abstract] [Full Text] [Related]

  • 19. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
    Wagstaff JD, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1996 Aug 15; 278(2):547-54. PubMed ID: 8768703
    [Abstract] [Full Text] [Related]

  • 20. Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats.
    Baracz SJ, Everett NA, McGregor IS, Cornish JL.
    Addict Biol; 2016 Mar 15; 21(2):316-25. PubMed ID: 25399704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.